BrainsWay Ltd.

BRSYF ·Healthcare, Medical Devices, Israel
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017
Operating Activities
Net Income $2.9M $-4.2M $-13.3M $-6.5M $-5.4M $-10.3M $-6.5M $-7.1M
Depreciation & Amortization — — — — — — — —
Depreciation — — — — — — — —
Amortization — — — — — — — —
Stock-Based Compensation — — — — — — — —
Net Cash from Operating Activities $10.3M $1.3M $-9.8M $884.0K $-1.4M $-7.2M $-3.8M $-3.5M
Investing Activities
Capital Expenditures — — — $2.2M $2.5M $3.3M $2.0M $985.0K
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $30.3M $-37.4M $42.2M $-42.2M $-2.5M $-2.4M $-1.1M $-2.5M
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $18.3M $-1.0M $-1.5M $41.5M $-1.0M $22.5M $-265.0K $11.1M
Net Change in Cash $58.8M $-37.1M $30.7M $-40.0K $-4.7M $12.7M $-5.5M $5.3M
Free Cash Flow — — — $-1.4M $-3.9M $-10.6M $-5.7M $-4.5M